Themis Medicare Limited

Company Profile

Themis Medicare Limited had its IPO on under the ticker symbol THEMISMED.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Themis Medicare Limited has a staff strength of 996 employees.

Stock update

Shares of Themis Medicare Limited opened at ₹1680 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹1575.1 - ₹1680, and closed at ₹1585.2.

This is a -2.26% slip from the previous day's closing price.

A total volume of 413 shares were traded at the close of the day’s session.

In the last one week, shares of Themis Medicare Limited have slipped by -2.02%.

Themis Medicare Limited's Key Ratios

Themis Medicare Limited has a market cap of ₹14.68 billion, indicating a price to book ratio of 3.3071 and a price to sales ratio of 2.9246.

In the last 12-months Themis Medicare Limited’s revenue was ₹3.57 billion with a gross profit of ₹2.36 billion and an EBITDA of ₹687.53 million. The EBITDA ratio measures Themis Medicare Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Themis Medicare Limited’s operating margin was 16.2% while its return on assets stood at 7.56% with a return of equity of 18.15%.

In Q2, Themis Medicare Limited’s quarterly earnings growth was a positive 4.5% while revenue growth was a positive 2.3%.

Themis Medicare Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

25.4791

PEG

Its diluted EPS in the last 12-months stands at ₹62.62 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Themis Medicare Limited’s profitability.

Themis Medicare Limited stock is trading at a EV to sales ratio of 3.0675 and a EV to EBITDA ratio of 11.9384. Its price to sales ratio in the trailing 12-months stood at 2.9246.

Themis Medicare Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.31% and a payout ratio of 11.67%.

Balance sheet and cash flow metrics

Total Assets

₹5.14 billion

Total Liabilities

₹1.39 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

11.67%

Themis Medicare Limited ended 2024 with ₹5.14 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹5.14 billion while shareholder equity stood at ₹3.39 billion.

Themis Medicare Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.39 billion in other current liabilities, in common stock, ₹1.93 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹125.47 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹284.46 million.

Themis Medicare Limited’s total current assets stands at ₹2.65 billion while long-term investments were ₹0 and short-term investments were ₹112.62 million. Its net receivables were ₹1.45 billion compared to accounts payable of ₹400.45 million and inventory worth ₹689.52 million.

In 2024, Themis Medicare Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Themis Medicare Limited paid ₹0.12 in dividends in 2024.

Other key metrics

Current Trading Price

₹1585.2

52-Week High

₹1727.4

52-Week Low

₹776.4969

Analyst Target Price

₹

Themis Medicare Limited stock is currently trading at ₹1585.2 per share. It touched a 52-week high of ₹1727.4 and a 52-week low of ₹1727.4. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹1556.59 and 200-day moving average was ₹1375.9 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7849.5% of the company’s stock are held by insiders while 0% are held by institutions.